IVPH -- INNOVIVE Pharmaceuticals | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
IVPH -- INNOVIVE Pharmaceuticals

An SI Board Since August 2007

Posts	SubjectMarks	Bans	Symbol
117	3	0	IVPH.OB

Emcee: scaram(o)uche	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
17	>>INNOVIVE Pharmaceuticals to Present at the Paramount BioSciences Annual	tuck	-	10/19/2007
16	Can anyone tell me why the pps is going down?? Seems like this company is heade	bookert11	-	10/19/2007
15	>>INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designatio	tuck	-	10/15/2007
14	call was actually on the seventeenth. you can go here... merrimanco.com click on	ewolf	-	9/18/2007
13	Adam Craig has left. Wasn't that long ago he left ArQule, was it? Bouncy g	tuck	-	9/18/2007
12	Interesting. Often wondered what giving an MHC class II inducer would do in com	scaram(o)uche	-	9/18/2007
11	Seems like the few people on here knows a little about the company. What r u guy	bookert11	-	9/13/2007
10	IP check might not be easy . . . check this from 2004: >>Drugs R	tuck	-	9/12/2007
9	[Tamibarotene induces MHC II in MM cells] >> Haematologica. 2007 Jan;92(1	tuck	-	9/12/2007
8	>>SGX Provides Update on BCR-ABL Collaboration Monday September 10, 4:46 p	tuck	-	9/10/2007
7	>>INNOVIVE Pharmaceuticals Acquires Exclusive Rights to Develop and Commer	tuck	-	9/10/2007
6	INNO-206 protocol: clinicaltrials.gov Started in May. I can find no PR, but t	tuck	-	9/6/2007
5	Tuck, we went over this once before. :) sgx is designing a small molecule drug	rkrw	-	8/22/2007
4	[NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a	tuck	-	8/21/2007
3	[INNO-406 P1 in Ph+ CML and ALL] >>A phase I study of INNO-406, a dual in	tuck	-	8/21/2007
2	[INNO-406 suppresses the growth of Ph+ leukemia cells in the central nervous sys	tuck	-	8/21/2007
1	Cash and cash equivalents totaled $9.6 million at June 30, 2007. As of August 1	scaram(o)uche	-	8/21/2007

Go to reply# or date (mm/dd/yy):